Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 2
1979 7
1980 10
1981 8
1982 12
1983 12
1984 14
1985 22
1986 26
1987 30
1988 26
1989 32
1990 27
1991 40
1992 62
1993 55
1994 69
1995 87
1996 85
1997 104
1998 125
1999 112
2000 159
2001 178
2002 214
2003 241
2004 328
2005 431
2006 503
2007 530
2008 740
2009 830
2010 906
2011 1126
2012 1285
2013 1624
2014 1883
2015 2128
2016 2191
2017 2341
2018 2655
2019 2982
2020 3567
2021 787
Text availability
Article attribute
Article type
Publication date

Search Results

25,650 results
Results by year
Filters applied: . Clear all
Page 1
Global prevalence and major risk factors of diabetic retinopathy.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY; Meta-Analysis for Eye Disease (META-EYE) Study Group. Yau JW, et al. Among authors: xu l. Diabetes Care. 2012 Mar;35(3):556-64. doi: 10.2337/dc11-1909. Epub 2012 Feb 1. Diabetes Care. 2012. PMID: 22301125 Free PMC article. Review.
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Zhong WZ, Wang Q, Mao WM, Xu ST, Wu L, Shen Y, Liu YY, Chen C, Cheng Y, Xu L, Wang J, Fei K, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yan HH, Yang XN, Zhou Q, Wu YL; ADJUVANT investigators. Zhong WZ, et al. Among authors: xu l. Lancet Oncol. 2018 Jan;19(1):139-148. doi: 10.1016/S1470-2045(17)30729-5. Epub 2017 Nov 21. Lancet Oncol. 2018. PMID: 29174310 Clinical Trial.
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma.
Sun Y, Wu L, Zhong Y, Zhou K, Hou Y, Wang Z, Zhang Z, Xie J, Wang C, Chen D, Huang Y, Wei X, Shi Y, Zhao Z, Li Y, Guo Z, Yu Q, Xu L, Volpe G, Qiu S, Zhou J, Ward C, Sun H, Yin Y, Xu X, Wang X, Esteban MA, Yang H, Wang J, Dean M, Zhang Y, Liu S, Yang X, Fan J. Sun Y, et al. Among authors: xu l. Cell. 2021 Jan 21;184(2):404-421.e16. doi: 10.1016/j.cell.2020.11.041. Epub 2020 Dec 23. Cell. 2021. PMID: 33357445
Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, Liu MQ, Wei L, Nasser MI, Xu LY, Zhu P, Zhao MY. Lei HY, et al. Among authors: xu ly. Biomed Pharmacother. 2021 Jan;133:111064. doi: 10.1016/j.biopha.2020.111064. Epub 2020 Nov 28. Biomed Pharmacother. 2021. PMID: 33378966 Free PMC article. Review.
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia.
Verhoeven VJ, Hysi PG, Wojciechowski R, Fan Q, Guggenheim JA, Höhn R, MacGregor S, Hewitt AW, Nag A, Cheng CY, Yonova-Doing E, Zhou X, Ikram MK, Buitendijk GH, McMahon G, Kemp JP, Pourcain BS, Simpson CL, Mäkelä KM, Lehtimäki T, Kähönen M, Paterson AD, Hosseini SM, Wong HS, Xu L, Jonas JB, Pärssinen O, Wedenoja J, Yip SP, Ho DW, Pang CP, Chen LJ, Burdon KP, Craig JE, Klein BE, Klein R, Haller T, Metspalu A, Khor CC, Tai ES, Aung T, Vithana E, Tay WT, Barathi VA; Consortium for Refractive Error and Myopia (CREAM), Chen P, Li R, Liao J, Zheng Y, Ong RT, Döring A; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Evans DM, Timpson NJ, Verkerk AJ, Meitinger T, Raitakari O, Hawthorne F, Spector TD, Karssen LC, Pirastu M, Murgia F, Ang W; Wellcome Trust Case Control Consortium 2 (WTCCC2), Mishra A, Montgomery GW, Pennell CE, Cumberland PM, Cotlarciuc I, Mitchell P, Wang JJ, Schache M, Janmahasatian S, Igo RP Jr, Lass JH, Chew E, Iyengar SK; Fuchs' Genetics Multi-Center Study Group, Gorgels TG, Rudan I, Hayward C, Wright AF, Polasek O, Vatavuk Z, Wilson JF, Fleck B, Zeller T, Mirshahi A, Müller C, Uitterlinden AG, Rivadeneira F, Vingerling JR, Hofman A, Oostra BA, Amin N, Bergen AA, Teo YY, Rahi JS, Vitart V, Williams C, Baird PN, Wong TY, Oexle K, Pfeiffer N, Mackey DA, Young TL, van Duijn CM, Saw SM, Bailey-Wilson JE, Stambolian D, Klaver CC, Hammond CJ. Verhoeven VJ, et al. Among authors: xu l. Nat Genet. 2013 Mar;45(3):314-8. doi: 10.1038/ng.2554. Epub 2013 Feb 10. Nat Genet. 2013. PMID: 23396134 Free PMC article.
Biomarkers of inflammation and repair in kidney disease progression.
Puthumana J, Thiessen-Philbrook H, Xu L, Coca SG, Garg AX, Himmelfarb J, Bhatraju PK, Ikizler TA, Siew ED, Ware LB, Liu KD, Go AS, Kaufman JS, Kimmel PL, Chinchilli VM, Cantley LG, Parikh CR. Puthumana J, et al. Among authors: xu l. J Clin Invest. 2021 Feb 1;131(3):e139927. doi: 10.1172/JCI139927. J Clin Invest. 2021. PMID: 33290282 Free PMC article.
New drug targets for hypertension: A literature review.
Gao Q, Xu L, Cai J. Gao Q, et al. Among authors: xu l. Biochim Biophys Acta Mol Basis Dis. 2021 Mar 1;1867(3):166037. doi: 10.1016/j.bbadis.2020.166037. Epub 2020 Dec 9. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 33309796 Free article. Review.
Computational Methods in Heterogeneous Catalysis.
Chen BWJ, Xu L, Mavrikakis M. Chen BWJ, et al. Among authors: xu l. Chem Rev. 2021 Jan 27;121(2):1007-1048. doi: 10.1021/acs.chemrev.0c01060. Epub 2020 Dec 22. Chem Rev. 2021. PMID: 33350813
25,650 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page